USPTO trademark

LONFUTRI

Under examinationUSPTOWord markClass 5

"LONFUTRI" is a word mark owned by Intellia Therapeutics, Inc., filed at the USPTO on July 2, 2026. It is under examination and covers class 5 (Pharmaceuticals).

View Intellia Therapeutics, Inc. portfolioGet this data via the API
Official USPTO record
LONFUTRI trademark as filed
As filed with the USPTO
Status
Under examination
Since August 19, 2026
Filed
July 2, 2026
Registered
Not yet
Expires
Not recorded
Application no.
99918600
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
1 class
Ownership

Who owns LONFUTRI

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Intellia Therapeutics, Inc.

NTLA · Cambridge, United States

20 trademarks in the portfolioView company

Representative

Karen K. Won

Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C

Goods and services

What the mark covers

The products and services LONFUTRI is filed for, grouped by Nice class.

  • Pharmaceutical and biological preparations; Pharmaceutical and biological preparations for use as a gene editing therapy; Pharmaceutical preparations for the treatment of hereditary angioedema; Pharmaceutical and biological preparations for treating and managing hereditary angioedema (HAE) and complications caused by hereditary angioedema (HAE); Pharmaceutical and biological preparations for use as a one-time treatment for hereditary angioedema (HAE) due to C1 esterase inhibitor deficiency (Type 1 or Type 2); Pharmaceutical and biological preparations for use as a gene editing therapy that inactivates the KLKB1 gene and lowers plasma prekallikrein levels; Pharmaceutical and biological preparations for use as a gene editing therapy for hereditary angioedema (HAE); Pharmaceutical and biological preparations, namely, gene editing preparations for treating and managing swelling attacks; Therapeutic agents in the nature of a CRISPR/Cas9 system for treating hereditary angioedema (HAE)

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Teas change of correspondence received
  2. Applicant/correspondence changes (non-responsive) entered
  3. Teas change of owner address received
  4. Teas change of correspondence received
  5. Attorney/dom.rep.revoked and/or appointed
  6. Teas revoke/app/change addr of atty/dom rep received
  7. Applicant/correspondence changes (non-responsive) entered
  8. Teas change of owner address received
  9. Teas change of correspondence received
  10. Attorney/dom.rep.revoked and/or appointed

8 earlier steps on the official record.

FAQ

About LONFUTRI

Who owns the trademark "LONFUTRI"?

The USPTO trademark "LONFUTRI" (application 99918600) is owned by Intellia Therapeutics, Inc.

What is the status of "LONFUTRI"?

Its status at the USPTO is: under examination.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull LONFUTRI and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019f281a-9a99-7231-b973-5534690399dc
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019f281a-9a99-7231-b973-5534690399dc",
  "object": "trademark",
  "mark_text": "LONFUTRI",
  "status": {
    "primary": "pending",
    "stage": "examining"
  },
  "office_code": "US",
  "application_number": "99918600",
  "filing_date": "2026-07-02",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "Intellia Therapeutics, Inc.",
      "entity_id": "ent_019eb70a-ad62-7032-a246-031d34afc7b9"
    }
  ]
}